ClinTec & HCG Celebrate Partnership

Mar 2010

Dr Rabinder Buttar, PhD. President & CEO of ClinTec International and Frank S. Kilpatrick, President of Healthcare Communications Group (HCG), El Segundo, C A will celebrate their companies’ successful collaboration at the upcoming 22nd Annual Drug Information Association (DIA) EuroMeeting in Monaco on March 8-10, 2010. more...

BioLAGO Facilitates Cancer Therapy Project

Mar 2010

Hope for breast cancer patients – under the leadership of the Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), a cross border cooperation is to start between hospitals and bioanalytical laboratories of the Rhine Valley and Lake Constance region. more...

Intellicig On Top Of The Research World

Mar 2010

Leading electronic cigarette brand Intellicig has been accepted into one of the world's top centres for biomedical research.To make their products the healthiest and cleanest on the market, Intellicig has established a laboratory at Manchester’s Bioscience Incubator to perform their own clinical trials on their products. more...

New Biocitech CEO Jean-François Boussard

Mar 2010

Biocitech SAS, the Paris life science technology park, today announced that its board has appointed Jean-François Boussard as CEO with effect from April 1st. Jean-François Boussard replaces Jacques Lhomel, who is taking retirement to pursue a number of personal projects. more...

Michael J. Fox Made Honorary Doctor

Mar 2010

The renowned advocate and actor Michael J. Fox is to be made honorary doctor of medicine at Karolinska Institutet in recognition of his work raising funds and awareness for Parkinson’s disease as the founder of the Michael J. Fox Foundation for Parkinson’s Research (MJFF). more...

International NanoMicroClub Launched

Mar 2010

The Nanotechnology Knowledge Transfer Network (NanoKTN), and the Institute of Nanotechnology (IoN), has announced its collaboration that with the support of Technology Strategy Board funding, will encourage and support global business development for UK SMEs. more...

Integromics & TATAA Biocenter Collaborate

Mar 2010

Integromics S.L., the leading provider of bioinformatics solutions to gene expression researchers, has announced an exciting collaboration with the TATAA Biocenters in Sweden and the Czech Republic, to provide expert training in qPCR data analysis using RealTime StatMiner. more...

PA Consulting & ERBI Cambridge Seminar

Mar 2010

A seminar and dinner held on 26 January at Clare College Cambridge for emerging companies and their investors focusing on Adapting to life in the new economic environment – the challenge for start-ups attracted full attendance, demonstrating that venture-backed companies may be ahead in planning for the future and leading the UK out of recession. more...

Almac Expands Radiolabelling Facilities

Mar 2010

Almac, an integrated contract development and manufacturing organization supporting the international pharmaceutical and biotechnology industries, has further enhanced its radiolabelling capabilities with a significant facility expansion. more...

Hiroshi Uchida President & CEO of Magellan

Mar 2010

Magellan Biosciences, Inc., an emerging leader in
clinical diagnostics, announced that Hiroshi Uchida, Ph.D., has joined the company as president and chief
executive officer. He will also serve as a company director. Dr. Uchida (50) has more than 20 years of
leadership experience in the global medical technology and management consulting industries. more...

imaGenes Roche NimbleGen Certification

Mar 2010

Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce that imaGenes GmbH, located in Berlin, Germany, has passed the certification process to qualify as a Roche NimbleGen Certified Service Provider (CSP) for DNA Methylation Analysis. more...

Imperial Innovations Leads £5.6m Investment

Mar 2010

Imperial Innovations Group plc (AIM: IVO, 'Innovations'), a leading technology commercialisation and investment company, has led a £5.6m funding round in Myotec Therapeutics, with an investment of £2.8m to fund the development of novel treatments in the field of wasting diseases. Co-investor Invesco Perpetual also provided £2.8m. more...

Lloyds Banking Backs Alliance Pharma

Mar 2010

Lloyds Banking Group has provided the speciality AIM listed pharmaceutical company, Alliance Pharma with a £4m loan facility to enable it to purchase the trade and certain assets of Cambridge Laboratories. The funding package allows Alliance Pharma to increase its product portfolio, with an additional 18 prescription products across several therapeutic areas including a range of oncology products. more...

Sigma-Aldrich New Life Science Brand

Mar 2010

Sigma-Aldrich(R) (NASDAQ: SIAL) today unveiled its new Sigma(R) Life Science brand and website platform, designed to elevate the Company's current focus on biology and provide a single destination where researchers can access deep biological knowledge and market-leading products and technologies. more...

Cresset Establishes Versaphor Division

Mar 2010

Cresset today announced that it has launched Versaphor, a new desktop applications division aimed at supplying high quality tools based on its molecular Fields technology to a range of markets, including: medicinal chemists, patent teams (internal and external counsel), pre-clinical safety teams and in-licensing teams. more...

Cellular Dynamics & Roche Workshop

Mar 2010

Cellular Dynamics International (CDI) and Hoffmann-La Roche Inc. (Roche) today announced a workshop to be held during the Society of Toxicology Annual Meeting in Salt Lake City, UT, on March 7 - 11. more...

Sentrx Launches New Web Site

Mar 2010

Sentrx, a pioneer in outsourcing drug safety solutions for the biopharmaceutical industry, has redesigned its Web site, revealing a broader array of services, a client-focused attitude, and an improved ability to connect directly with key experts and leaders. more...

Polyplus-transfection licenses metabion

Mar 2010

Polyplus-transfection SA, announced today that metabion GmbH has signed a non-exclusive agreement to manufacture and commercialize Polyplus-transfection's Zip Nucleic Acid (ZNA (TM)) oligonucleotides, a new technology that increases affinity for nucleic acids. more...

NICE Reassessment Brings Little Hope

Mar 2010

The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE’s provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS’s successful appeal of negative NICE guidance on switching in 2007. more...

Nobel Laureate Publishes Recent Work

Mar 2010

Dr. Marshall. W. Nirenberg, Nobel Prize winning geneticist from NIH, published his last and most recent work in Current Chemical Genomics (http://www.bentham.org/open/tochgenj/). more...

Industry Ignores Talent Management

Mar 2010

A new survey of nearly 400 life sciences executives found that over 90% identify talent management as a key priority for 2010. However, only 26% have an active strategy in place for retaining talent and 68% have no clear leadership succession plan. more...

Stem Cells Experts At BioWales 2010

Mar 2010

Leading international names in Stem Cell technology Dr. Stephen Minger, Professor Sir Martin Evans and Anthony Davies will be talking about the latest significant developments in the field at the eighth BioWales bioscience event taking place near Cardiff over March 17 and 18 (www.biowalesevent.com). more...

Gentronix Agreement With GlaxoSmithKline

Mar 2010

Gentronix Limited Manchester, UK announced today that it has entered into a three year agreement with GlaxoSmithKline (GSK) to provide GreenScreen HC and BlueScreen HC genotoxicity assays for use by GSK in genotoxicity screening.
more...

Thermo Adds The Winvale Group

Feb 2010

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that The Winvale Group has become a member of its Informatics Global Partner Alliance. The Winvale Group, a total-solutions consultancy specializing in government procurement and the GSA Schedule program, will provide Thermo Fisher informatics solutions for federal, state and local governments operating under GSA Schedule 70. more...

Symbion Announces Integration

Feb 2010

Symbion Systems, Inc., a leader in providing analytical instrument control, analysis, and connectivity software, today announced the availability of its SCI-IP01 software driver to interface with the Infometrix line of chemometrics products. more...

OGT 1st High-Throughput Microarray Provider

Feb 2010

Following almost two years as an Agilent microarray Certified Service Provider, Oxford Gene Technology (OGT) and Agilent Technologies, Inc. (NYSE: A), today announced that OGT is the first company to be named as a High-Throughput Certified Service Provider (HT CSP) for Agilent microarrays. more...

imaGenes Adds NimbleGen Certification

Feb 2010

Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) is pleased to announce that imaGenes GmbH, located in Berlin, Germany, has passed the certification process to qualify as a Roche NimbleGen Certified Service Provider (CSP) for DNA Methylation Analysis. more...

Brady Labels Board The Frozen Ark

Feb 2010

Skin cells from endangered animals are grown in tissue culture at London’s Institute of Zoology, labelled using Brady’s BBP™11 printer and stored in liquid nitrogen as part of the global Frozen Ark Project. more...

Recipharm & Cobra Combine

Feb 2010

Recipharm AB is pleased to announce that following the successful acquisition of Cobra Biomanufacturing plc, it has now combined it with the existing Biologics activities located in Sweden. The integrated business will be known as RecipharmCobra Biologics and will operate as Recipharm’s specialist biologics division. more...

BioServe Partners with DNA Genotek

Feb 2010

BioServe, a leading provider of human biomaterial and genomic research services, today announced that it has completed validation testing of the Oragene·DNA saliva collection kits and has joined DNA Genotek's Partner Program. Now, BioServe can offer customers a comprehensive testing platform for extraction and genetic analysis for Oragene·DNA samples. more...